从脾论治糖尿病性便秘的研究进展
Research Progress on Treating Diabetic Constipation from the Spleen
摘要: 糖尿病性便秘为糖尿病常见的并发症之一,其发病率高,容易反复发作,严重影响患者的生活质量及血糖控制。西医对于糖尿病性便秘的治疗往往选取开塞露、乳果糖等相关药物进行干预,虽疗效快,但在糖尿病患者中,便秘现象发作频繁,反复给予这些药物易使患者产生依赖性,引发焦虑等症。祖国医学认为,脾主运化,为气血生化之源、气机升降之枢,且脾失健运在糖尿病性便秘的整个发病过程中居于核心地位。本文系统梳理从脾论治糖尿病性便秘的理论渊源与病因病机,归纳健脾益气、行气导滞、润肠通便等治法体系,总结中医内治联合中医特色外治的相关临床应用进展,对从脾论治糖尿病性便秘进行系统的综述,为临床治疗2型糖尿病性便秘提供理论依据与指导。
Abstract: Diabetic constipation is one of the common complications of diabetes mellitus. It has a high incidence rate, is prone to recurrent episodes, and severely affects patients’ quality of life and glycemic control. In Western medicine, treatments for diabetic constipation often involve medications such as glycerin enemas lactulose. Although these interventions produce rapid effects, constipation episodes occur frequently in diabetic patients. Repeated administration of these drugs can easily lead to drug dependence and trigger anxiety. Traditional Chinese medicine holds that the spleen governs transportation and transformation, serving as the source of qi and blood production and the pivot of ascending and descending of qi movement. Moreover, spleen failing in transportation and transformation occupies a central position throughout the pathogenesis of diabetic constipation. This paper systematically reviews the theoretical origins and etiology and pathogenesis of treating diabetic constipation from the perspective of the spleen, summarizes the therapeutic systems including invigorating the spleen and supplementing qi, promoting qi movement to relieve stagnation, and moistening the intestines to unblock the bowels, and synthesizes the progress in related clinical applications of combined internal traditional Chinese medicine therapy with characteristic external treatments. By providing a systematic review of treating diabetic constipation from the perspective of the spleen, this paper aims to offer a theoretical basis and guidance for the clinical treatment of type 2 diabetic constipation.
文章引用:朱淑芳, 蒲蔚荣. 从脾论治糖尿病性便秘的研究进展[J]. 中医学, 2026, 15(7): 74-79. https://doi.org/10.12677/tcm.2026.157361

参考文献

[1] 王菁, 朱延涛, 楼百层. 近5年中医药治疗糖尿病性便秘研究进展[J]. 新中医, 2021, 53(5): 6-9.
[2] 孙雪萍. 甘舒霖30R联合二甲双胍治疗2型糖尿病的效果[J]. 中国医药指南, 2022, 20(2): 118-120.
[3] 庞国明, 倪青, 张芳. 2型糖尿病病证结合诊疗指南[J]. 中医杂志, 2021, 62(4): 361-368.
[4] Abdu Seid, M., Diress, M., Mohammed, A., et al. (2023) Chronic Constipation and Its Associated Factors in Patients with Type-2 Diabetes: A Multicenter Cross-Sectional Study. Diabetes Research and Clinical Practice, 204, Article 110905.
[5] 高玉涛, 卢旭东, 丁晓青. 四磨汤联合乳果糖口服溶液、双歧杆菌三联活菌肠溶胶囊治疗老年糖尿病便秘临床观察[J]. 河北中医, 2023, 45(6): 926-929.
[6] 卢旭东, 韩亚青, 丁晓青, 等. 双歧杆菌三联活菌联合乳果糖, 四磨汤治疗老年2型糖尿病便秘的临床效果[J]. 临床误诊误治, 2024, 37(2): 112-117.
[7] 王冰. 黄帝内经素问[M]. 沈阳: 辽宁科学技术出版社, 1997: 76.
[8] 王冰. 灵枢经[M]. 沈阳: 辽宁科学技术出版社, 1997: 33.
[9] (金)李东垣. 脾胃论[M]. 文魁, 丁国华, 整理. 北京: 人民卫生出版社, 2005.
[10] 王谧, 王艳, 陈超. 基于聚类分析的糖尿病胃轻瘫患者中医证候分布规律研究[J]. 国际医药卫生导报, 2024, 30(13): 2210-2213.
[11] 胡燕敏, 伊娜, 王文英, 等. 早发2型糖尿病中医证型与危险因素及生化指标的关联性研究[J]. 广州中医药大学学报, 2023, 40(12): 2957-2964.
[12] 黄帝内经·素问[M]. 北京: 中国医药科技出版社, 2011.
[13] 祁木森, 王莉. 从脾论治2型糖尿病伴便秘[J]. 中国医药科学, 2024, 14(7): 96-99+185.
[14] 任静, 李宇思, 李会敏, 等. 基于肠道菌群探讨从脾虚论治糖尿病便秘[J]. 世界中西医结合杂志, 2024, 19(2): 399-403+414.
[15] 张洁, 陈雪妍, 姚美丹, 等. 中医药治疗糖尿病便秘用药规律探讨[J]. 安徽医药, 2023, 27(2): 404-408.
[16] 谷雨明, 徐云生. 徐云生诊治糖尿病性便秘经验浅析[J]. 江苏中医药, 2017, 49(2): 25-26.
[17] 周俊羽, 刘德山. 基于“阴火”探析糖尿病便秘治疗[J]. 亚太传统医药, 2025, 21(1): 185-188.
[18] 何建华. 从肝脾论治糖尿病性便秘[J]. 中医研究, 2011, 24(6): 6-8.
[19] 李清奇, 李青青, 宋晓明, 等. 润魄汤加减配合艾灸治疗老年2型糖尿病便秘临床效果及对中医证候及复发的影响[J]. 黑龙江中医药, 2023, 52(5): 150-152.
[20] 符丽, 刘燕娟, 曾远娴, 等. 大黄粉贴敷神阙穴结合天枢穴拍打治疗糖尿病便秘的疗效观察[J]. 中医临床研究, 2016, 8(4): 130-132.
[21] 何科贤. 耳穴三联疗法治疗气阴两虚夹瘀证糖尿病性便秘临床观察[J]. 国医论坛, 2025, 40(1): 40-43.
[22] 何炼英, 童露露, 李建英, 等. 揿针疗法对老年2型糖尿病性便秘及血糖的影响[J]. 中国老年保健医学, 2025, 23(2): 55-58.
[23] 李庆耀, 孙丹丹, 郑丽娟, 等. 白术的水溶性化学成分及其促肠动力活性研究[J]. 井冈山大学学报(自然科学版), 2024, 45(5): 73-80.
[24] 陈文东, 王孝停, 黄琪, 等. 生白术与炒白术对功能性便秘大鼠肠道微生物群落结构的影响及作用机制[J]. 中草药, 2025, 56(14): 5098-5107.
[25] 曲中原, 李苏楠, 孙志伟, 等. 枳实化学成分与治疗功能性消化不良关联性分析及实验验证[J]. 中草药, 2022, 53(20): 6521-6528.
[26] 姚奇, 周茜, 任东林, 等. 黄芪甲苷对特发性胃瘫大鼠c-kit蛋白表达及Cajal间质细胞的影响[J]. 广西医科大学学报, 2021, 38(8): 1485-1490.
[27] 翟孟凡, 贾小强, 王泽鹏, 等. “黄芪-白术”药对治疗功能性便秘的网络药理学机制[J]. 世界中医药, 2021, 16(10): 1514-1519.
[28] 巨红叶, 王俊, 吴飞飞, 等. 基于气津理论探讨黄芪增液汤治疗结肠慢传输型便秘作用机制[J]. 现代中医药, 2023, 43(4): 91-96.